More info
Active ingredients
Bifidobacterium longum + enterococcus fetium
Composition
Enterococcus faecium not less than 107 cfu Bifidobacterium longum not less than 107 cfu
Pharmacological effect
Eubiotic. The strains of Enterococcus faecium and Bifidobacterium longum, which are part of the preparation, are natural symbiotic bacteria that inhabit the gastrointestinal tract. The drug has a normalizing effect on the quantitative and qualitative composition of the intestinal microflora. The action is due both to the direct direct effect of the constituents of the preparation (high antagonistic activity against pathogenic and conditionally pathogenic microorganisms), and indirectly - stimulation of the local intestinal immunity (activation of the synthesis of immunoglobulin A, induction of the synthesis of endogenous interferon). Bifidobacterium longum has a high survival rate in the human intestine and a high growth rate. The inclusion of the pathogenic enterococcus Enterococcus faecium, which normally colonizes the small intestine, makes it possible to exert a positive effect on the state and digestive functions of not only the colon, but also the small intestine, especially in the presence of fermenting dyspepsia and meteorism.
Indications
- diarrhea caused by acute and exacerbation of chronic gastroenteritis, rotavirus infection; - antibiotic-associated diarrhea; - traveler's diarrhea; - in the treatment of acute intestinal infections; - in the treatment of chronic gastrointestinal diseases such as colitis, irritable bowel syndrome and other gastrointestinal disorders of functional genesis; - normalization of intestinal microflora, treatment and prevention of dysbacteriosis and maintenance of the immune system in children over 2 years old and adults; - lactose intolerance; - as part of a comprehensive standard eradication therapy in patients with Helicobacter pylori infection.
Contraindications
- individual hypersensitivity to the drug.
Use during pregnancy and lactation
The use of the drug Bifiform during pregnancy and lactation is considered safe because the drug is not absorbed and does not have a systemic effect.
Dosage and administration
In acute diarrhea, the drug must be taken 1 capsule 4 times a day until stool is normalized.Then the drug should be continued in a dose of 2-3 capsules per day until the complete disappearance of symptoms. To normalize the intestinal microflora and support the immune system, the drug is prescribed in a dose of 2-3 capsules per day 10-21 days. Patients with lactose intolerance are advised to take the drug 1 capsule 3 times a day. When conducting eradication therapy, Bifiform prescribed 2 capsules 2 times a day for two weeks from the first day of eradication therapy. Children from 2 years on 1 capsule 2-3 times a day. If the child cannot swallow the capsule, it is necessary to open and mix the contents with a small amount of liquid.
Side effects
When used in recommended doses, according to established indications, no side effects have been identified.
Overdose
Overdose symptoms not previously reported. In the case of a significant excess of the recommended doses, it is advisable medical observation.
Interaction with other drugs
The drug can be used in combination with other drugs. Simultaneous administration with antibiotics is permitted.
special instructions
Precautions: do not exceed the maximum daily dose. Influence on the ability to drive motor vehicles and control mechanisms The drug does not affect the ability to drive a car and control mechanisms.